Published in Cancer Weekly, May 13th, 1996
In order to explore gene therapy as a new treatment modality for HCC, Hanzian Huang et al., of the Baylor College of Medicine, established an orthotopic cancer model by intrahepatic implantation of a HCC cell line in syngeneic mice. Results were presented at the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, DC.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.